2025 Volume 48 Issue 11 Pages 1753-1761
“Antibody engineering” is a promising strategy for generating high-affinity antibodies required for developing sensitive immunoassays. Therein, the variable domains (VH and VL) of the parental antibody are genetically randomized and combined to produce diverse single-chain Fv fragment (scFv) molecules. Subsequently, high-affinity scFv mutants are selectively isolated. In the randomization process, mutations have conventionally been targeted to the complementarity-determining regions (CDRs) in the variable domains, which often interact directly with antigens. However, we previously discovered that, pinpoint insertion of only a single amino acid (leucine, asparagine, aspartic acid, proline, glutamine, arginine, or histidine) between positions 6 and 7 in the framework region 1 (FR1) of the VH, which is unlikely to interact with antigens, enhanced the affinity of an anti-cortisol scFv (original Ka, 3.6 × 108 M−1) up to 17–61-fold. These findings prompted us to conduct a comprehensive study of this affinity-enhancement phenomenon involving the remaining amino acids. Thus, we generated the necessary 13 scFv mutants and compared their Ka values. Remarkably, all mutants showed enhanced affinities, similar to those of the previous 7 mutants. Among the 20 mutants, the leucine-inserted scFv showed the largest Ka (2.2 × 1010 M−1) and consequently enabled a 75-fold more sensitive enzyme-linked immunosorbent assay (midpoint, 9.86 pg/assay) compared to the assay using the parental scFv (midpoint, 744 pg/assay). In silico modeling suggested that, regardless of the amino acid inserted, elongated FR1 can alter the conformation of the CDR3 in VH to facilitate a favorable interaction with cortisol.